PISKEL KYLE 4
4 · Adaptive Biotechnologies Corp · Filed Mar 17, 2025
Insider Transaction Report
Form 4
PISKEL KYLE
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-14$6.32/sh+2,500$15,800→ 271,510 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-14−2,500→ 0 totalExercise: $6.32Exp: 2026-11-08→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The option was fully vested and exercisable.